Skip to main

Clarus Therapeutics Holdings

CRXT is nowCRXTQ
CRXT logo
This stock has changed its ticker name. This happens for a variety of reason, including a corporate merger or simply a change in company name.
Learn More

Frequently Asked Questions (FAQ)

As of Jun 26, 2025, the market cap for CRXT stock is $72.8K

The 52-week high for CRXT stock is $3.94. The current CRXT stock price $undefined is 100.00% below its 52-week high

The 52-week low for CRXT stock is $0.00. The current CRXT stock price $undefined has increased 100.00% from its 52-week low

No, the CRXT stock does not pay dividends to its shareholders

How to buy CRXT stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in CRXT stock

    Navigate to the Explore page. Then, type CRXT into the search bar. When you see CRXT stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased CRXT stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Clarus Therapeutics Holdings Stock Earnings

The value each CRXT share was expected to gain vs. the value that each CRXT share actually gained.

CRXT (CRXT) reported Q2 2022 earnings per share (EPS) of -$0.29, meeting estimates of -$0.29 by 0.00%. In the same quarter last year, CRXT's earnings per share (EPS) was $0. CRXT is expected to release next earnings on 08/18/2022, with an earnings per share (EPS) estimate of $0.

Buy CRXT Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.